Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 10/11/23 → 10/11/27 |
Funding
- Cumberland Pharmaceuticals Inc.: $6,378.00
Central Nervous System Penetration and Plasma Pharmacokinetics of Telavancin in Critically Ill Patients
- Cook, Aaron (PI)
- Burgess, David (CoI)